News
The Michael Jon Barlin Pediatric Lupus Research program provides funding for research projects that have the potential to ...
The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab ...
There are multiple chapters near you. Select your preferred chapter.
Researchers from EMD Serono and global collaborators shared promising results from Cohort B of the phase II trial of the WILLOW study.
In this Lupus & You recording, medical experts and guest speakers share insights that challenge the misconception that lupus only affects women. Learn about the experiences of men living with lupus, ...
There’s no special “lupus diet” you need to follow. Just follow these tips on building a balanced diet with healthy foods you enjoy.
Lupus affects different people in different ways. Many people with lupus have problems with their liver. How does lupus affect the liver? Your liver helps your body digest food and filters waste out ...
Lupus can cause a lot of different skin problems, and there are many different kinds of medicines that can treat them. A special doctor called a dermatologist can help you find a treatment plan that ...
Today at the American College of Rheumatology (ACR) Annual Meeting, Convergence 2024, the ACR released a summary of a new guideline for the screening, treatment and management of lupus nephritis ...
If you’ve been diagnosed with lupus, you probably have a lot of questions about the disease and how it may affect your life. Lupus affects different people in different ways. For some, lupus can be ...
AMPEL BioSolutions announced the launch of LuGENE®, an exciting breakthrough innovation in systematic lupus erythematosus (SLE) care. LuGENE® is a new blood test designed to predict SLE flares before ...
Today, the U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA) for Gazyva® (Obinutuzumab), for the potential treatment of lupus nephritis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results